Literature DB >> 10703837

Amyloid-beta junkies.

G Perry, A Nunomura, A K Raina, M A Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10703837     DOI： 10.1016/S0140-6736(05)72173-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  19 in total

1.  Do neurons have a choice in death?

Authors:  G Perry; X Zhu; M A Smith
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

2.  Protective effect of zinc on amyloid-beta 25-35 and 1-40 mediated toxicity.

Authors:  S M Cardoso; A C Rego; C Pereira; C R Oliveira
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

3.  Amyloid-beta vaccination: testing the amyloid hypothesis?: heads we win, tails you lose!

Authors:  Hyoung-gon Lee; Xiongwei Zhu; Akihiko Nunomura; George Perry; Mark A Smith
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

Review 4.  Treating the lesions, not the disease.

Authors:  Xiongwei Zhu; Jesus Avila; George Perry; Mark A Smith
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

5.  The fallacy of amyloid and cognition in Alzheimer's disease.

Authors:  Hyoung-gon Lee; Xiongwei Zhu; George Perry; Mark A Smith
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

6.  Pathology's new role: defining disease process and protective responses.

Authors:  George Perry; Rudy J Castellani; Paula I Moreira; Hyoung-Gon Lee; Xiongwei Zhu; Mark A Smith
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

Review 7.  Novel therapeutics for Alzheimer's disease: an update.

Authors:  David J Bonda; Hyun-Pil Lee; Hyoung-gon Lee; Avi L Friedlich; George Perry; Xiongwei Zhu; Mark A Smith
Journal:  Curr Opin Drug Discov Devel       Date:  2010-03

Review 8.  Alzheimer's disease pathologic cascades: who comes first, what drives what.

Authors:  Russell H Swerdlow
Journal:  Neurotox Res       Date:  2011-09-13       Impact factor: 3.911

Review 9.  Parallels between major depressive disorder and Alzheimer's disease: role of oxidative stress and genetic vulnerability.

Authors:  Roberto Rodrigues; Robert B Petersen; George Perry
Journal:  Cell Mol Neurobiol       Date:  2014-06-14       Impact factor: 5.046

10.  Frontiers in Alzheimer's disease therapeutics.

Authors:  Jeremy G Stone; Gemma Casadesus; Kasia Gustaw-Rothenberg; Sandra L Siedlak; Xinglong Wang; Xiongwei Zhu; George Perry; Rudy J Castellani; Mark A Smith
Journal:  Ther Adv Chronic Dis       Date:  2011-01-01       Impact factor: 5.091
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.